Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.54 USD | +1.07% | +0.21% | +69.11% |
May. 24 | Surface Transforms and FRP placings oversubscribed | AN |
May. 16 | Pennant Group Acquires Hospice Provider Nurses on Wheels | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With an expected P/E ratio at 29.43 and 24.91 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+69.11% | 707M | D+ | ||
-4.11% | 2.98B | B- | ||
-.--% | 1.93B | - | ||
+23.65% | 1.86B | C | ||
-11.21% | 461M | - | ||
-47.58% | 298M | - | ||
-19.40% | 174M | - | ||
-16.45% | 131M | - | ||
+1.92% | 67.77M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PNTG Stock
- Ratings The Pennant Group, Inc.